Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,257 total articles
Global Ship Lease, a leading containership owner, announced solid first quarter 2026 results including operating revenues of $198.1 million, net income of $91.4 million, and adjusted EBITDA of $133.2 million. The company has locked in forward contract coverage for 100% of 2026 and 86% of 2027, totaling over $2 billion in contracted revenues. They d…
SBC Medical Group Holdings Incorporated, a Nasdaq-listed U.S. medical services company, announced the opening of a new aesthetic dermatology section at BLEZ CLINIC in Bangkok through its consulting partner BLEZ ASIA. The new section, launching services in June 2026, will offer Japanese-standard aesthetic treatments such as pico laser for pigmentati…
Black Diamond Therapeutics announced that CEO Mark Velleca will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York on June 3, 2026. The company plans one-on-one investor meetings and will webcast the presentation, highlighting its clinical-stage oncology focus on innovative MasterKey therapies targeting oncogen…
SunPower Inc. has closed an additional $5 million private placement on its April senior convertible debenture notes, bringing total funding to $46 million. The funds will support intra-quarter liquidity for general corporate purposes. The company is focused on reducing overhead costs from prior acquisitions and aims to achieve steady-state cashflow…
ABM Industries Incorporated announced the release of its fiscal second quarter 2026 financial results on June 5, 2026, prior to market opening. The company will host a conference call and webcast for investors to discuss the results, with a replay available for 90 days. ABM is a leading provider of integrated facility solutions serving diverse sect…
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company, received a notification from Nasdaq regarding non-compliance with listing rules due to the late filing of its Form 10-Q for the quarterly period ending March 31, 2026. The company has until July 20, 2026, to submit a plan to regain compliance and is currently working to complet…
BitFuFu Inc., a leading Bitcoin mining company listed on NASDAQ under ticker FUFU, announced it will release its unaudited financial results for the first quarter of 2026 on May 29, 2026, before the U.S. market opens. The management will hold an earnings conference call the same day to discuss the results. The company specializes in Bitcoin mining …
Repligen Corporation, a leader in bioprocessing technologies, announced its participation in the William Blair 46th Annual Growth Stock Conference with a presentation by its CEO on June 3rd. The presentation will provide a company overview and highlight its focus on innovative bioprocessing technologies supporting biological drug manufacturing.
BriaCell Therapeutics announced positive clinical data from its Phase 2 and ongoing Phase 3 studies evaluating Bria-IMT immunotherapy in heavily pre-treated metastatic breast cancer patients. The data highlighted median overall survival improvements, preserved quality of life, and biomarker analyses supporting predictors of response. No safety conc…
Assembly Biosciences, a Nasdaq-listed biotechnology company, announced the pricing of a $100 million offering of common stock and pre-funded warrants. The proceeds are intended to support the clinical development of its pipeline candidates targeting serious viral and liver diseases. The offering attracted participation from new and existing investo…
Regeneron Pharmaceuticals announced that the European Medicines Agency (EMA) has accepted for review under Accelerated Assessment the Marketing Authorization Application for Otarmeni™ (lunsotogene parvec), a gene therapy for biallelic OTOF variant-associated hearing loss. Otarmeni is already approved in the U.S. and this approval could mark the fir…
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery and advanced radiation therapy services, announced its 2026 Annual Shareholder Meeting to be held virtually on June 24, 2026. Shareholders of record on April 27, 2026, are eligible to participate and vote. The company continues to focus on expanding inte…
Assembly Biosciences, Inc. announced the expansion of its clinical development program for ABI-6250, an oral entry inhibitor originally targeted for chronic hepatitis delta virus (HDV) infection, to include primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). A Phase 2 study focusing on these cholestatic liver diseases is exp…
Chagee Holdings Limited, a premium tea drinks brand listed on NASDAQ under the ticker CHA, announced it will report its first quarter 2026 financial results on May 28, 2026. The company will hold a conference call to discuss the results and engage with investors, continuing its commitment to transparency and communication.
Concorde International Group Ltd. (NASDAQ: YOOV), a technology-enabled security solutions provider, was featured in the official World FM Day 2026 video by the Singapore International Facility Management Association. The company’s proprietary operational security model, protected by patents in 29 jurisdictions, has been recognized for driving indus…
Destination XL Group, Inc. announced it is reviewing an unsolicited $0.82 per share cash tender offer from Zodiac Partners II, LLC while balancing its fiduciary duties and an existing merger agreement with FBB Holdings I, Inc. The Board is consulting financial and legal advisors to decide on a recommendation for shareholders, who are advised to tak…
AC Immune SA reported new Phase 1 data demonstrating that its TDP-43 PET tracer ACI-19626 has higher uptake in the brains of patients with amyotrophic lateral sclerosis (ALS), indicating its potential to detect TDP-43 pathology. This early detection capability may enable precision medicine approaches for neurodegenerative diseases such as ALS and f…
Rocket Lab Corporation announced the successful deployment of the ninth satellite for Synspective using its Electron rocket, reinforcing its position as the premier small satellite launch provider. The mission advances Synspective's synthetic aperture radar Earth observation constellation and demonstrates Rocket Lab's commitment to tailored launch …
LyondellBasell announced a quarterly dividend of $0.69 per share payable on June 8, 2026, with an ex-dividend date of June 1, 2026. The company highlights its leadership in the global chemical industry and focus on sustainable innovations.
FTAI Aviation Ltd., a US-listed company (NASDAQ: FTAI), announced the successful pricing of its inaugural asset-backed securitization (ABS) under its Strategic Capital vehicle, raising $612 million through the issuance of two classes of investment grade notes backed by a portfolio of 48 narrowbody aircraft leased to 23 global airlines. The transact…
Yimutian Inc. announced the full deployment of its WolaiCai AI Agent across all platforms, achieving over 200 million daily token consumption and generating approximately US$3,000 in daily revenue from agricultural AI products. The AI agent improves transaction efficiency between buyers and sellers in agricultural trading by automating procurement …
Lixiang Education Holding Co., Ltd. announced successful compliance with Nasdaq's minimum bid price requirement following a 1-for-10 reverse stock split, resolving previous non-compliance issues and securing continued listing on the exchange.
NIO Inc., a leading global smart electric vehicle manufacturer, announced its Annual General Meeting to be held on June 24, 2026, in Shanghai. The company also released its annual report (Form 20-F) for the fiscal year ended December 31, 2025, filed with the U.S. SEC. NIO's board supports the proposed resolutions to be voted on at the AGM. Voting i…
BioNTech SE announced encouraging clinical trial updates from its late-stage oncology pipeline at the 2026 ASCO Annual Meeting. Data highlights include positive anti-tumor activity of pumitamig in first-line non-small cell lung cancer and gotistobart showing durable activity in platinum-resistant ovarian cancer. The company continues to advance ove…
NervGen Pharma Corp., a clinical-stage biopharmaceutical company focused on neuroreparative therapies, announced an underwritten public offering of 24 million common shares and accompanying warrants priced at $2.50 each, raising approximately $60 million before expenses. The proceeds will be used to advance their lead candidate NVG-291 through clin…
